VOYA Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.11M | Sell |
536,304
-89,186
| -14% | -$693K | 0.01% | 827 |
|
|
2025
Q4 | $4.88M | Buy |
625,490
+169,899
| +37% | +$1.23M | ﹤0.01% | 875 |
|
|
2025
Q3 | $3.46M | Sell |
455,591
-25,210
| -5% | -$210K | ﹤0.01% | 1021 |
|
|
2025
Q2 | $4.31M | Sell |
480,801
-16,011
| -3% | -$149K | ﹤0.01% | 1014 |
|
|
2025
Q1 | $3.73M | Sell |
496,812
-129,093
| -21% | -$1.04M | ﹤0.01% | 1058 |
|
|
2024
Q4 | $4.71M | Sell |
625,905
-257,912
| -29% | -$1.96M | ﹤0.01% | 996 |
|
|
2024
Q3 | $6.72M | Buy |
883,817
+36,973
| +4% | +$281K | 0.01% | 893 |
|
|
2024
Q2 | $5.23M | Sell |
846,844
-152,472
| -15% | -$841K | 0.01% | 984 |
|
|
2024
Q1 | $5.08M | Buy |
999,316
+172,699
| +21% | +$971K | 0.01% | 997 |
|
|
2023
Q4 | $4.95M | Sell |
826,617
-101,035
| -11% | -$585K | 0.01% | 1005 |
|
|
2023
Q3 | $6.57M | Buy |
927,652
+142,843
| +18% | +$1.03M | 0.01% | 865 |
|
|
2023
Q2 | $5.53M | Buy |
784,809
+180,398
| +30% | +$1.45M | 0.01% | 950 |
|
|
2023
Q1 | $5.04M | Sell |
604,411
-162,604
| -21% | -$1.57M | 0.01% | 986 |
|
|
2022
Q4 | $8.81M | Buy |
767,015
+138,987
| +22% | +$1.73M | 0.01% | 761 |
|
|
2022
Q3 | $7.91M | Buy |
628,028
+58,879
| +10% | +$758K | 0.01% | 788 |
|
|
2022
Q2 | $6.02M | Buy |
569,149
+495,483
| +673% | +$5.11M | 0.02% | 670 |
|
|
2022
Q1 | $1.2M | Buy |
73,666
+2,364
| +3% | +$37.9K | ﹤0.01% | 1365 |
|
|
2021
Q4 | $987K | Buy |
71,302
+2,084
| +3% | +$27.6K | ﹤0.01% | 1552 |
|
|
2021
Q3 | $995K | Sell |
69,218
-1,451
| -2% | -$22.9K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $1.12M | Sell |
70,669
-6,961
| -9% | -$94.6K | ﹤0.01% | 1562 |
|
|
2021
Q1 | $789K | Buy |
77,630
+969
| +1% | +$9.99K | ﹤0.01% | 1741 |
|
|
2020
Q4 | $571K | Buy |
76,661
+17,886
| +30% | +$92.2K | ﹤0.01% | 1835 |
|
|
2020
Q3 | $202K | Buy |
58,775
+5,820
| +11% | +$24.9K | ﹤0.01% | 2148 |
|
|
2020
Q2 | $252K | Sell |
52,955
-25,055
| -32% | -$100K | ﹤0.01% | 2050 |
|
|
2020
Q1 | $156K | Buy |
78,010
+5,772
| +8% | +$15.9K | ﹤0.01% | 2216 |
|
|
2019
Q4 | $249K | Buy |
72,238
+26,639
| +58% | +$67K | ﹤0.01% | 2269 |
|
|
2019
Q3 | $131K | Hold |
45,599
| – | – | ﹤0.01% | 2344 |
|
|
2019
Q2 | $173K | Hold |
45,599
| – | – | ﹤0.01% | 2341 |
|
|
2019
Q1 | $371K | Hold |
45,599
| – | – | ﹤0.01% | 1946 |
|
|
2018
Q4 | $368K | Buy |
45,599
+3,442
| +8% | +$26.8K | ﹤0.01% | 1914 |
|
|
2018
Q3 | $322K | Hold |
42,157
| – | – | ﹤0.01% | 2116 |
|
|
2018
Q2 | $242K | Hold |
42,157
| – | – | ﹤0.01% | 2272 |
|
|
2018
Q1 | $201K | Hold |
42,157
| – | – | ﹤0.01% | 2311 |
|
|
2017
Q4 | $207K | Buy |
42,157
+3,882
| +10% | +$18.8K | ﹤0.01% | 2331 |
|
|
2017
Q3 | $201K | Hold |
38,275
| – | – | ﹤0.01% | 2382 |
|
|
2017
Q2 | $213K | Buy |
38,275
+4,127
| +12% | +$25.1K | ﹤0.01% | 2377 |
|
|
2017
Q1 | $287K | Hold |
34,148
| – | – | ﹤0.01% | 2075 |
|
|
2016
Q4 | $216K | Hold |
34,148
| – | – | ﹤0.01% | 2252 |
|
|
2016
Q3 | $151 | Hold |
34,148
| – | – | ﹤0.01% | 2390 |
|
|
2016
Q2 | $97K | Hold |
34,148
| – | – | ﹤0.01% | 2477 |
|
|
2016
Q1 | $97K | Hold |
34,148
| – | – | ﹤0.01% | 2403 |
|
|
2015
Q4 | $352K | Hold |
34,148
| – | – | ﹤0.01% | 1955 |
|
|
2015
Q3 | $389K | Sell |
34,148
-6,049
| -15% | -$80.7K | ﹤0.01% | 1884 |
|
|
2015
Q2 | $600K | Hold |
40,197
| – | – | ﹤0.01% | 1784 |
|
|
2015
Q1 | $363K | Hold |
40,197
| – | – | ﹤0.01% | 2118 |
|
|
2014
Q4 | $489K | Hold |
40,197
| – | – | ﹤0.01% | 1942 |
|
|
2014
Q3 | $393K | Hold |
40,197
| – | – | ﹤0.01% | 2057 |
|
|
2014
Q2 | $513K | Buy |
+40,197
| New | +$391K | ﹤0.01% | 1962 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC